APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Inactivated Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Japanese Encephalitis Inactivated Vaccine Market Analysis and Forecast 2026-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Inactivated Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Inactivated Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Inactivated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Inactivated Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Inactivated Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Inactivated Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Japanese Encephalitis Inactivated Vaccine include Liaoning Chengda Biological Co., Ltd, Lanzhou Institute of Biological Products Co., Ltd, Chengdu Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Valneva, Sanofi Pasteur and Biken, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Japanese Encephalitis Inactivated Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Japanese Encephalitis Inactivated Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Japanese Encephalitis Inactivated Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Japanese Encephalitis Inactivated Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Japanese Encephalitis Inactivated Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Japanese Encephalitis Inactivated Vaccine sales, projected growth trends, production technology, application and end-user industry.

Japanese Encephalitis Inactivated Vaccine Segment by Company

Liaoning Chengda Biological Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Valneva

Sanofi Pasteur

Biken

Japanese Encephalitis Inactivated Vaccine Segment by Type

Adult

Child

Japanese Encephalitis Inactivated Vaccine Segment by Application

Hospital

Clinic

Japanese Encephalitis Inactivated Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Inactivated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Inactivated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Inactivated Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Japanese Encephalitis Inactivated Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Japanese Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Japanese Encephalitis Inactivated Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adult Major Manufacturers Table 3. Child Major Manufacturers Table 4. Global Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Japanese Encephalitis Inactivated Vaccine Industry Trends Table 8. Japanese Encephalitis Inactivated Vaccine Industry Drivers Table 9. Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges Table 10. Japanese Encephalitis Inactivated Vaccine Industry Restraints Table 11. Global Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Japanese Encephalitis Inactivated Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Japanese Encephalitis Inactivated Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Japanese Encephalitis Inactivated Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Japanese Encephalitis Inactivated Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Japanese Encephalitis Inactivated Vaccine Manufacturers, Product Type & Application Table 29. Global Japanese Encephalitis Inactivated Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Japanese Encephalitis Inactivated Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Japanese Encephalitis Inactivated Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Japanese Encephalitis Inactivated Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Liaoning Chengda Biological Co., Ltd Company Information Table 57. Liaoning Chengda Biological Co., Ltd Business Overview Table 58. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 60. Liaoning Chengda Biological Co., Ltd Recent Development Table 61. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 62. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 63. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 65. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 66. Chengdu Institute of Biological Products Co., Ltd Company Information Table 67. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 68. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 70. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 71. Beijing Institute of Biological Products Co., Ltd Company Information Table 72. Beijing Institute of Biological Products Co., Ltd Business Overview Table 73. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 75. Beijing Institute of Biological Products Co., Ltd Recent Development Table 76. Valneva Company Information Table 77. Valneva Business Overview Table 78. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 80. Valneva Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. Biken Company Information Table 87. Biken Business Overview Table 88. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 90. Biken Recent Development Table 91. North America Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 94. North America Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 95. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 96. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 97. North America Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 100. North America Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 101. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 102. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 103. North America Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 108. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 109. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 110. North America Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 111. United States Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 112. Canada Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 116. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 117. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 118. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 119. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 122. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 123. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 124. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 125. Europe Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. Europe Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 130. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 131. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 132. Europe Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 133. Germany Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 134. France Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 135. U.K. Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 136. Italy Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 138. China Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 139. China Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 140. China Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 141. China Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 142. China Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 143. China Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 144. China Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 145. China Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 146. China Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 147. China Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 148. China Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 149. China Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Asia Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 153. Asia Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 154. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 155. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 156. Asia Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 159. Asia Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 160. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 161. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. Asia Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 167. Asia Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 168. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 169. Asia Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 170. Japan Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 171. South Korea Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 172. India Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Australia Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 174. China Taiwan Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 179. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 180. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 181. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 182. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 185. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 186. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 187. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 188. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 192. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 193. SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 194. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 195. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Brazil Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Argentina Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Chile Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Colombia Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Peru Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Israel Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 203. UAE Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Turkey Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Iran Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Egypt Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Japanese Encephalitis Inactivated Vaccine Distributors List Table 210. Japanese Encephalitis Inactivated Vaccine Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Japanese Encephalitis Inactivated Vaccine Image Figure 2. Global Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Inactivated Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adult Image Figure 5. Child Image Figure 6. Global Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Japanese Encephalitis Inactivated Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Japanese Encephalitis Inactivated Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Japanese Encephalitis Inactivated Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Japanese Encephalitis Inactivated Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Japanese Encephalitis Inactivated Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Japanese Encephalitis Inactivated Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Japanese Encephalitis Inactivated Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Japanese Encephalitis Inactivated Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Japanese Encephalitis Inactivated Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Japanese Encephalitis Inactivated Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Japanese Encephalitis Inactivated Vaccine Sales Share by Type (2021-2032) Figure 40. North America Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Japanese Encephalitis Inactivated Vaccine Sales Share by Application (2021-2032) Figure 42. North America Japanese Encephalitis Inactivated Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Japanese Encephalitis Inactivated Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Japanese Encephalitis Inactivated Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Japanese Encephalitis Inactivated Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Japanese Encephalitis Inactivated Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Japanese Encephalitis Inactivated Vaccine Sales Share by Country (2021-2032) Figure 50. China Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2021-2032) Figure 51. China Japanese Encephalitis Inactivated Vaccine Sales Share by Type (2021-2032) Figure 52. China Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2021-2032) Figure 53. China Japanese Encephalitis Inactivated Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Japanese Encephalitis Inactivated Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Japanese Encephalitis Inactivated Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Japanese Encephalitis Inactivated Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Japanese Encephalitis Inactivated Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Japanese Encephalitis Inactivated Vaccine Sales Share by Country (2021-2032) Figure 66. Japanese Encephalitis Inactivated Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Japanese Encephalitis Inactivated Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • Liaoning Chengda Biological Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Valneva
  • Sanofi Pasteur
  • Biken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Japanese Encephalitis Inactivated Vaccine Market by Type
  3. 1.2.1 Global Japanese Encephalitis Inactivated Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adult
  5. 1.2.3 Child
  6. 1.3 Japanese Encephalitis Inactivated Vaccine Market by Application
  7. 1.3.1 Global Japanese Encephalitis Inactivated Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Japanese Encephalitis Inactivated Vaccine Market Dynamics
  1. 2.1 Japanese Encephalitis Inactivated Vaccine Industry Trends
  2. 2.2 Japanese Encephalitis Inactivated Vaccine Industry Drivers
  3. 2.3 Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Inactivated Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Japanese Encephalitis Inactivated Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region
  3. 3.2.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Japanese Encephalitis Inactivated Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Japanese Encephalitis Inactivated Vaccine Sales by Region
  9. 3.4.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Japanese Encephalitis Inactivated Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Manufacturers
  6. 4.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Japanese Encephalitis Inactivated Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Japanese Encephalitis Inactivated Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Japanese Encephalitis Inactivated Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Japanese Encephalitis Inactivated Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Japanese Encephalitis Inactivated Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Japanese Encephalitis Inactivated Vaccine Tier 1, Tier 2, and Tier 3
5 Japanese Encephalitis Inactivated Vaccine Market by Type
  1. 5.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type
  2. 5.1.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Type
  6. 5.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Japanese Encephalitis Inactivated Vaccine Price by Type
6 Japanese Encephalitis Inactivated Vaccine Market by Application
  1. 6.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application
  2. 6.1.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Application
  6. 6.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Japanese Encephalitis Inactivated Vaccine Price by Application
7 Company Profiles
  1. 7.1 Liaoning Chengda Biological Co., Ltd
  2. 7.1.1 Liaoning Chengda Biological Co., Ltd Company Information
  3. 7.1.2 Liaoning Chengda Biological Co., Ltd Business Overview
  4. 7.1.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  6. 7.1.5 Liaoning Chengda Biological Co., Ltd Recent Developments
  7. 7.2 Lanzhou Institute of Biological Products Co., Ltd
  8. 7.2.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  9. 7.2.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  10. 7.2.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  12. 7.2.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  13. 7.3 Chengdu Institute of Biological Products Co., Ltd
  14. 7.3.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  15. 7.3.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  16. 7.3.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  18. 7.3.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  19. 7.4 Beijing Institute of Biological Products Co., Ltd
  20. 7.4.1 Beijing Institute of Biological Products Co., Ltd Company Information
  21. 7.4.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  22. 7.4.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  24. 7.4.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  25. 7.5 Valneva
  26. 7.5.1 Valneva Company Information
  27. 7.5.2 Valneva Business Overview
  28. 7.5.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio
  30. 7.5.5 Valneva Recent Developments
  31. 7.6 Sanofi Pasteur
  32. 7.6.1 Sanofi Pasteur Company Information
  33. 7.6.2 Sanofi Pasteur Business Overview
  34. 7.6.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio
  36. 7.6.5 Sanofi Pasteur Recent Developments
  37. 7.7 Biken
  38. 7.7.1 Biken Company Information
  39. 7.7.2 Biken Business Overview
  40. 7.7.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio
  42. 7.7.5 Biken Recent Developments
8 North America
  1. 8.1 North America Japanese Encephalitis Inactivated Vaccine Market Size by Type
  2. 8.1.1 North America Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
  5. 8.2 North America Japanese Encephalitis Inactivated Vaccine Market Size by Application
  6. 8.2.1 North America Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
  9. 8.3 North America Japanese Encephalitis Inactivated Vaccine Market Size by Country
  10. 8.3.1 North America Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Japanese Encephalitis Inactivated Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Type
  2. 9.1.1 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Application
  6. 9.2.1 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country
  10. 9.3.1 Europe Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Japanese Encephalitis Inactivated Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Japanese Encephalitis Inactivated Vaccine Market Size by Type
  2. 10.1.1 China Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
  5. 10.2 China Japanese Encephalitis Inactivated Vaccine Market Size by Application
  6. 10.2.1 China Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Japanese Encephalitis Inactivated Vaccine Market Size by Type
  2. 11.1.1 Asia Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Japanese Encephalitis Inactivated Vaccine Market Size by Application
  6. 11.2.1 Asia Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Japanese Encephalitis Inactivated Vaccine Market Size by Country
  10. 11.3.1 Asia Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Japanese Encephalitis Inactivated Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Japanese Encephalitis Inactivated Vaccine Market Size by Type
  2. 12.1.1 SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Japanese Encephalitis Inactivated Vaccine Market Size by Application
  6. 12.2.1 SAMEA Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Japanese Encephalitis Inactivated Vaccine Market Size by Country
  10. 12.3.1 SAMEA Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Japanese Encephalitis Inactivated Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Japanese Encephalitis Inactivated Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Japanese Encephalitis Inactivated Vaccine Value Chain Analysis
  2. 13.1.1 Japanese Encephalitis Inactivated Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Japanese Encephalitis Inactivated Vaccine Production Mode & Process
  6. 13.2 Japanese Encephalitis Inactivated Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Japanese Encephalitis Inactivated Vaccine Distributors
  9. 13.2.3 Japanese Encephalitis Inactivated Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst